Stock DNA
Commercial Services & Supplies
INR 108 Cr ()
12.00
36
0.00%
0.00
0.00%
2.57
Total Returns (Price + Dividend) 
Telge Projects for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Statement Of Deviation Or Variation For Half Year And Year Ended March 31 2026.
29-May-2026 | Source : BSEStatement of Deviation or Variation for half year and year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
22-May-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) Regulations 2015 copy of transcript of earnings call held on May 19 2026 for Audited Financial Results for quarter and year ended March 31 2026 is enclosed.
Announcement under Regulation 30 (LODR)-Investor Presentation
19-May-2026 | Source : BSEInvestor Presentation for Financial Year ended March 31 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 2 FIIs (1.74%)
Shraddha Shailesh Telge (71.5%)
Aarth Aif Growth Fund (2.76%)
13.98%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 14.53% vs 10.49% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 63.46% vs 100.00% in Dec 2025
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 21.86% vs 52.90% in Mar 2025
YoY Growth in year ended Mar 2026 is -29.77% vs 51.09% in Mar 2025